A recent publication from Audrey G\u00e9rard\u2019s lab looks at how a specific protein, called IFN\u03b3, can coordinate CD8+ T cell responses during a flu infection.
Ruth Nanjala, DPhil student in Molecular and Cellular Medicine funded by the Africa Oxford Initiative (AfOx) Kennedy Trust Prize Studentship, attended a reception at Buckingham Palace hosted by King Charles III and Queen Camilla to mark the 60th anniversary of Kenya\u2019s independence. Ruth was invited in her capacity as student leader within the Oxford University Africa Society (AfriSoc).
The Kennedy Trust for Rheumatology Research (KTRR) visited the Kennedy Institute in early October. The Institute benefits extensively from the generous support of the KTRR and the visit was a great opportunity to share stories of our scientific successes and discuss future directions.
We welcome Fr\u00e4nze Progatzky who joined us this month as a new Principal Investigator, establishing her research group to study how glial cells in the nervous system of the gut and the lungs maintain healthy organs and drive responses to infection and injury.
Marco Fritzsche has been honoured in the 2023 Recognition of Distinction Scheme, the University of Oxford\u2019s annual exercise to confer the title of full professor for excellence in research and teaching.
The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at NDORMS and across the University of Oxford.
We welcome Calliope (Calli) Dendrou who joined the Kennedy Institute of Rheumatology this Summer as a Principal Investigator leading a research group. Calli is a leader in cross-disease multiomics and her research focuses on using omics (the study of totality of a molecular process in organisms) to find patterns shared by different inflammatory diseases, so that we can develop better treatments for these life-impacting conditions and repurpose existing treatments to help more people.
The lunch with sandwiches, tea and strawberries was attended by staff and students and provided an opportunity to give some well-earned Long Service Awards.
A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient\u2019s genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.
Huw Colin-York has been awarded a fellowship from the Engineering and Physical Sciences Research Council (EPSRC) to develop synthetic biology tools to understand the immune response.
A new type of macrophages recently identified in atherosclerotic lesions could provide a missing link in understanding the inflammatory origins of the common yet fatal condition.
A team led by Alex Clarke at the Kennedy Institute has identified how high mitochondrial activity regulates antibody responses crucial for immunity but is also necessary for the development of lymphoma.
Insights into a specific macrophage population suggest that these cells could drive inflammation in rheumatoid arthritis. Understanding their complex role could lead to better treatments for patients.
Absci will apply its generative AI platform to The Kennedy Institute\u2019s immunology biorepository to speed the discovery and development of multiple therapies
The Kennedy professor is one of eight researchers from Oxford University who received a prestigious fellowship from the Royal Society in recognition of their work in the fields of science and medicine.
A new study led by Oxford researchers has found vedolizumab can induce remission in patients who have chronic pouchitis after surgery for ulcerative colitis.
A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.
Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.
![\"T](\"https://www.kennedy.ox.ac.uk/news/new-discovery-furthers-our-understanding-of-how-critical-immune-cells-are-controlled-during-an-infection/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n